pubmed-article:17853492 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C1333899 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C1704218 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C1704387 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C1522642 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C0019728 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
pubmed-article:17853492 | lifeskim:mentions | umls-concept:C0368692 | lld:lifeskim |
pubmed-article:17853492 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17853492 | pubmed:dateCreated | 2008-1-17 | lld:pubmed |
pubmed-article:17853492 | pubmed:abstractText | Towards the goal of identifying tumor-rejection antigens on eradicated tumors in bone and soft tissue sarcomas, we evaluated the immune response against antigens presented by lost HLA class I molecules. Tumor specimens and peripheral blood samples were obtained from a 70-year-old woman with pleomorphic malignant fibrous histiocytoma. Over 1-year culture, a tumor cell line (MFH2004) was established. A B-cell line infected with Epstein-Barr virus (B2004-EBV) was developed from the blood samples. HLA genotypes of B2004-EBVcells were A*0206/2402, B*4006/4601, and C*0102/0801, whereas MFH2004 cells were defective for A*0206, B*4006, and C*0102. Loss of HLA-A2 expression was also proved immunohistochemically in the primary tumor tissues. Lost HLA-A2 in MFH2004 cells was retrieved by transfection of HLA-A*0206 cDNA to develop MFH2004-A2. Attempts to induce CTLs by mixed culture with autologous T cells and MFH2004 cells resulted in failure. In contrast, those with MFH2004-A2 induced CTL clones CTL2004-c6 and CTL2004-c17. These CTL clones specifically killed MFH2004-A2 but not MFH2004 or B2004-EBV in an HLA-A2-restricted manner. These findings suggest that CTL2004-c6 and CTL2004-c17 recognize autologous tumor-rejection antigens presented by HLA-A*0206, which may have been expressed by tumor cells that had been eradicated by the host's immunosurveillance system. | lld:pubmed |
pubmed-article:17853492 | pubmed:language | eng | lld:pubmed |
pubmed-article:17853492 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17853492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17853492 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17853492 | pubmed:month | Feb | lld:pubmed |
pubmed-article:17853492 | pubmed:issn | 1554-527X | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:SatoNoriyukiN | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:WadaTakuroT | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:YamashitaTosh... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:KawaguchiSato... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:IdaKazunoriK | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:TorigoeToshih... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:TsukaharaTomo... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:KimuraShigeha... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:MatsumuraTada... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:MuraseMasakiM | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:KozakaiYuriko... | lld:pubmed |
pubmed-article:17853492 | pubmed:author | pubmed-author:KayaMitunoriM | lld:pubmed |
pubmed-article:17853492 | pubmed:copyrightInfo | (c) 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. | lld:pubmed |
pubmed-article:17853492 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17853492 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:17853492 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17853492 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17853492 | pubmed:pagination | 271-8 | lld:pubmed |
pubmed-article:17853492 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:meshHeading | pubmed-meshheading:17853492... | lld:pubmed |
pubmed-article:17853492 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:17853492 | pubmed:articleTitle | Clonal T-cell response against autologous pleomorphic malignant fibrous histiocytoma antigen presented by retrieved HLA-A*0206. | lld:pubmed |
pubmed-article:17853492 | pubmed:affiliation | Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan. | lld:pubmed |
pubmed-article:17853492 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17853492 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:17853492 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3105 | entrezgene:pubmed | pubmed-article:17853492 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17853492 | lld:entrezgene |
lhgdn:association:33808 | lhgdn:found_in | pubmed-article:17853492 | lld:lhgdn |